Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial

Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:21:53.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:02:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:51:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:13:02.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:25:52.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new clinical trial involving nivolumab, ipilimumab, and panitumumab for treating unresectable refractory KRAS/NRAS/BRAF wild-type metastatic colorectal cancer, with a new principal investigator, Hanna K Sanoff, MD, and collaborators Amgen and Bristol-Myers Squibb.
    Difference
    48%
    Check dated 2025-04-16T20:39:07.000Z thumbnail image

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.